Comparison of the Efficiency of Transplantation of Rat and Human Olfactory Ensheathing Cells in Posttraumatic Cysts of the Spinal Cord


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Olfactory ensheathing cells showed significant effects on the regeneration of the spinal cord in experimental models and in clinical trials. However, the use of these cells in the therapy of posttraumatic cysts of the spinal cord has not been studied. Cultures of human and rat olfactory mucosa were obtained according to the protocols developed by us. Passage 3-4 cultures are most enriched with olfactory ensheathing cells and are preferable for transplantation. We performed transplantation of 750,000 olfactory ensheathing cells into the region of modeled cysts. The therapeutic effect of human cells was more pronounced. The positive dynamics of recovery of motor activity in the hind limbs of rats can reflect regenerative processes in the spinal cord after transplantation of olfactory ensheathing cells into the region of posttraumatic cysts.

About the authors

А. D. Voronova

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: nastyanastyav@mail.ru
Russian Federation, Moscow; Moscow

O. V. Stepanova

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

M. P. Valikhov

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

A. V. Chadin

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

А. S. Semkina

Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

M. A. Abakumov

Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

I. V. Reshetov

University Hospital No. 1, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow

V. P. Chekhonin

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation

Email: nastyanastyav@mail.ru
Russian Federation, Moscow; Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies